2 enrolling by invitation. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Enrolling by invitation 2 |
Follow REM Sleep Behavior Disorder: new trials by email Literature Review of REM Sleep Behavior Disorder trials Research Report on REM Sleep Behavior Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MIBG in Aging and Neurologic Disorders meta-iodobenzylguanidine (MIBG) (123I), 123I-MIBG scintigraphy - Lewy Body Disease, Dementia | Phase 4 | Enrolling by invitation | Mayo Clinic | 50 | 2023-05-08 | 2026-07-30 |
| DaTSCAN Imaging in Aging and Neurodegenerative Disease I-123 Ioflupane solution injection prior to SPECT scan (DaTscan), Single photon emission computed tomography (SPECT) scan - Dementia, Parkinsonism | Phase 4 | Enrolling by invitation | Mayo Clinic | 500 | 2011-10-01 | 2026-03-10 |
Cognitive Dysfunction (2) · Dementia (2) · Parkinsonian Disorders (2) · Lewy Body Disease (1)
Basal Ganglia Diseases (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Cognition Disorders (2) · Mental Disorders (2) · Movement Disorders (2) · Nervous System Diseases (2) · Neurocognitive Disorders (2) · Parasomnias (2) · REM Sleep Parasomnias (2) · Sleep Wake Disorders (2) · Neurodegenerative Diseases (1) · Synucleinopathies (1)
3-Iodobenzylguanidine (1) · Iodine-123 (1) · Radionuclide Imaging (1) · Tomography, Emission-Computed, Single-Photon (1) · ioflupane (1)
Mayo Clinic (2)
United States (2)
PMID 29560382, PMID 32198310, PMID 33348363, PMID 33408148, PMID 33422890, PMID 36844148